Placeholder Content Image

Opioids don’t relieve acute low back or neck pain – and can result in worse pain, new study finds

<p><em><a href="https://theconversation.com/profiles/christine-lin-346821">Christine Lin</a>, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a>; <a href="https://theconversation.com/profiles/andrew-mclachlan-255312">Andrew McLachlan</a>, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a>; <a href="https://theconversation.com/profiles/caitlin-jones-1263090">Caitlin Jones</a>, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a>, and <a href="https://theconversation.com/profiles/christopher-maher-826241">Christopher Maher</a>, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a></em></p> <p>Opioids are the one of the most prescribed pain-relief for people with low back and neck pain. In Australia, around <a href="https://link.springer.com/article/10.1007/s00586-017-5178-4">40% of people</a> with low back and neck pain who present to their GP and <a href="https://qualitysafety.bmj.com/content/28/10/826">70% of people</a> with low back pain who visit a hospital emergency department are prescribed opioids such as oxycodone.</p> <p>But our <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00404-X/fulltext">new study</a>, published today in the Lancet medical journal, found opioids do not relieve “acute” low back or neck pain (lasting up to 12 weeks) and can result in worse pain.</p> <p>Prescribing opioids for low back and neck pain can also cause <a href="https://www.healthdirect.gov.au/taking-opioid-medicines-safely">harms</a> ranging from common side effects – such as nausea, constipation and dizziness – to <a href="https://www.aihw.gov.au/reports/illicit-use-of-drugs/opioid-harm-in-australia/summary">misuse, dependency, poisoning and death</a>.</p> <p>Our findings show opioids should <em>not</em> be recommended for acute low back pain or neck pain. A change in prescribing for low back pain and neck pain is urgently needed in <a href="https://www.tga.gov.au/resources/publication/publications/addressing-prescription-opioid-use-and-misuse-australia">Australia</a> and <a href="https://www.thelancet.com/commissions/opioid-crisis">globally</a> to reduce opioid-related harms.</p> <h2>Comparing opioids to a placebo</h2> <p>In our trial, we randomly allocated 347 people with acute low back pain and neck pain to take either an opioid (oxycodone plus naloxone) or <a href="https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/placebo-effect">placebo</a> (a tablet that looked the same but had no active ingredients).</p> <p>Oxycodone is an opioid pain medicine which can be given orally. <a href="https://www.nps.org.au/radar/articles/oxycodone-with-naloxone-controlled-release-tablets-targin-for-chronic-severe-pain">Naloxone</a>, an opioid-reversal drug, reduces the severity of constipation while not disrupting the pain relieving effects of oxycodone.</p> <p>Participants took the opioid or placebo for a maximum of six weeks.</p> <p>People in the both groups also received <a href="https://www.sciencedirect.com/science/article/pii/S1836955321000941">education and advice</a> from their treating doctor. This could be, for example, advice on returning to their normal activities and avoiding bed rest.</p> <p>We assessed their outcomes over a one-year period.</p> <h2>What did we find?</h2> <p>After six weeks of treatment, taking opioids did not result in better pain relief compared to the placebo.</p> <p>Nor were there benefits to other outcomes such as physical function, quality of life, recovery time or work absenteeism.</p> <p>More people in the group treated with opioids experienced nausea, constipation and dizziness than in the placebo group.</p> <p>Results at one year highlight the potential long-term harm of opioids even with short-term use. Compared to the placebo group, people in the opioid group experienced slightly worse pain, and reported a higher risk of <a href="https://academic.oup.com/painmedicine/article/20/1/113/4728236#129780622">opioid misuse</a> (problems with their thinking, mood or behaviour, or using opioids differently from how the medicines were prescribed).</p> <p>More people in the opioid group reported pain at one year: 66 people compared to 50 in the placebo group.</p> <h2>What will this mean for opioid prescribing?</h2> <p>In recent years, international low back pain guidelines have shifted the focus of treatment from drug to non-drug treatment due to <a href="https://www.thelancet.com/article/S0140-6736(18)30489-6/fulltext">evidence</a> of limited treatment benefits and concern of medication-related harm.</p> <p>For acute low back pain, <a href="https://link.springer.com/article/10.1007/s00586-018-5673-2">guidelines</a> recommend patient education and advice, and if required, anti-inflammatory pain medicines such as ibuprofen. Opioids are <a href="https://link.springer.com/article/10.1007/s00586-018-5673-2">recommended only</a> when other treatments haven’t worked or aren’t appropriate.</p> <p>Guidelines for <a href="https://pubmed.ncbi.nlm.nih.gov/33064878/">neck</a> pain similarly discourage the use of opioids.</p> <p>Our latest research clearly demonstrates the benefits of opioids do not outweigh possible harms in people with acute low back pain and neck pain.</p> <p>Instead of advising opioid use for these conditions in selected circumstances, opioids should be discouraged without qualification.</p> <h2>Change is possible</h2> <p>Complex problems such as opioid use need smart solutions, and another study we recently conducted provides convincing data opioid prescribing can be successfully reduced.</p> <p>The <a href="https://qualitysafety.bmj.com/content/30/10/825">study</a> involved four hospital emergency departments, 269 clinicians and 4,625 patients with low back pain. The intervention comprised of:</p> <ul> <li>clinician education about <a href="https://aci.health.nsw.gov.au/networks/musculoskeletal/resources/low-back-pain">evidence-based management</a> of low back pain</li> <li>patient education using posters and handouts to highlight the benefits and harms of opioids</li> <li>providing heat packs and anti-inflammatory pain medicines as alternative pain-management treatments</li> <li>fast-tracking referrals to outpatient clinics to avoid long waiting lists</li> <li>audits and feedback to clinicians on information about opioid prescribing rates.</li> </ul> <p>This intervention reduced opioid prescribing from <a href="https://qualitysafety.bmj.com/content/30/10/825">63% to 51% of low back pain presentations</a>. The <a href="https://emj.bmj.com/content/early/2023/04/02/emermed-2022-212874">reduction was sustained for 30 months</a>.</p> <p>Key to this successful approach is that we worked with clinicians to develop suitable pain-management treatments without opioids that were feasible in their setting.</p> <p>More work is needed to evaluate this and other interventions aimed at reducing opioid prescribing in other settings including GP clinics.</p> <p>A nuanced approach is often necessary to avoid causing <a href="https://theconversation.com/opioid-script-changes-mean-well-but-have-left-some-people-in-chronic-pain-156753">unintended consequences</a> in reducing opioid use.</p> <p>If people with low back pain or neck pain are using opioids, especially at higher doses over an extended period of time, it’s important they seek advice from their doctor or pharmacist before stopping these medicines to avoid <a href="https://www.healthdirect.gov.au/opioid-withdrawal-symptoms">unwanted effects when the medicines are abruptly stopped</a>.</p> <p>Our research provides compelling evidence opioids have a limited role in the management of acute low back and neck pain. The challenge is getting this new information to clinicians and the general public, and to implement this evidence into practice.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/203244/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em><a href="https://theconversation.com/profiles/christine-lin-346821">Christine Lin</a>, Professor, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a>; <a href="https://theconversation.com/profiles/andrew-mclachlan-255312">Andrew McLachlan</a>, Head of School and Dean of Pharmacy, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a>; <a href="https://theconversation.com/profiles/caitlin-jones-1263090">Caitlin Jones</a>, Postdoctoral Research Associate in Musculoskeletal Health, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a>, and <a href="https://theconversation.com/profiles/christopher-maher-826241">Christopher Maher</a>, Professor, Sydney School of Public Health, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a></em></p> <p><em>Image credits: Shutterstock</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/opioids-dont-relieve-acute-low-back-or-neck-pain-and-can-result-in-worse-pain-new-study-finds-203244">original article</a>.</em></p>

Body

Placeholder Content Image

Pain relief without the risks: World-first discovery of opioid alternative found in Tasmanian mud

<p>Australian scientists think they have found the world’s first alternative to opioid pain relief. </p> <p>The catch? It is in the form of a tiny fungus. </p> <p>The organism was discovered 16 years ago embedded in mud on a boat ramp in Huon Valley, Tasmania. </p> <p>Researchers at the University of Sydney and Queensland University told<span> </span><a rel="noopener" href="https://www.9news.com.au/national/health-news-pain-killing-drugs-alternative-to-opioids-found/7e2e1c11-4895-47b8-b060-86963cef3b69" target="_blank">9News</a><span> </span>they discovered the fungus had an unusual molecule which looked almost identical to endorphins, used as a natural pain relief mechanism. </p> <p>"The molecules we've found hit that opioid receptor just as potent as morphine, but we are very hopeful we have good scientific evidence to believe that they will not have the same adverse side effects," Professor Rob Capon from the University of Queensland said. </p> <p>"No one has ever looked at microorganisms, bacteria and fungi before as a source of pain drugs."</p> <p>One of the dangerous side effects of opioids is that they are able to induce respiratory depression.</p> <p>However researchers are confident this new drug will provide the same pain relief without that risk. </p> <p>"Overdose deaths should decrease dramatically with this drug" Professor Macdonald Christie from the University of Sydney told reporters. </p> <p>"If it's not addictive, then that's even better, because part of the problem is people become addicted to opiates, they use too much, they start to use them illicitly and that's where the problem is."</p> <p>The drug is currently in the discovery phase and scientists are looking for industry partners to take up licenses to their patent. </p> <p>However, it may still be decades before the product hits shelves.</p>

News

Placeholder Content Image

Aussies “panic buying” codeine ahead of over-the-counter ban

<p>Last year, <a href="http://www.oversixty.com.au/health/body/2017/09/painkillers-will-become-harder-to-get/" target="_blank"><strong><span style="text-decoration: underline;">we reported</span></strong></a> that the Therapeutic Goods Administration (TGA) had decided to place new restrictions on the sale of codeine-containing medications, making them available by prescription only in response to the growing number of Australians becoming addicted to the drug.</p> <p>Now, just weeks before the February 1 deadline, there are reports of consumers flocking to pharmacies to stock up on the soon-to-be restricted drug.</p> <p>According to <a href="http://www.news.com.au/lifestyle/health/health-problems/panic-buying-as-codeine-overthecounter-ban-looms/news-story/9308d0bef9c7e049873ba1c64e906ae5" target="_blank"><strong><span style="text-decoration: underline;">news.com.au</span></strong></a>, people are “panic-buying” medications such as Panadeine, Nurofen Plus and Mersyndol, confirming the fears of the Pharmacy Guild of Australia who were staunchly against the over-the-counter ban, saying it will only lead to an increase in “doctor shopping”.</p> <p>Dr Chris Haynes, Dean of the Faculty of Pain Medicine at the Australian and New Zealand College of Anaesthetics, says there are effective alternatives to codeine available, but that patients should discuss options with their GP about how to best manage their pain.</p> <p>“Most people will be able to manage their short-term pain with a range of other, over the counter medicines that don’t contain codeine,” he told news.com.au.</p> <p>“But if you’re at all unsure seek advice on what the most appropriate medicines and pain relief are best suited for you. There are many safer and more effective alternatives available that don’t have the harmful side effects of low-dose codeine.”</p> <p>Dr Hayes welcomes the ban, explaining that codeine, a weak opioid, can be highly addictive and that overdose can lead to liver damage, stomach ulcers, renal failure and, in some cases, death.</p> <p>“Codeine should not be used to treat a migraine or period pain. There are significant costs to the patient, their families, public health resources and the community when patients become addicted to codeine,” he said.</p> <p>“When exploring other alternative treatments it’s good to be aware that unlike codeine, paracetamol and ibuprofen are not opioids and not addictive.”</p>

Body

Placeholder Content Image

The surprising prescription drug killing thousands of Australians

<p>When we think of deadly drugs, methamphetamine and heroin come to mind. However, startling new data from the Australian Bureau of Statistics has found a much more common (and legal) drug may be responsible for more deaths each year than both.</p> <p>Researchers from the National Drug and Alcohol Research Centre have found that, of the 668 overdose deaths in 2013, a staggering 68 per cent were related to pharmaceutical opioids.</p> <p>“We expect further increases once the deaths data for 2014 and 2015 are finalised,” lead author Amanda Roxburgh told the <a href="http://www.smh.com.au/national/health/prescription-opioids-are-killing-more-australians-than-heroin-australian-bureau-of-statistics-20170720-gxf5wa.html" target="_blank"><strong><em><span style="text-decoration: underline;">Sydney Morning Herald</span></em></strong></a>. “We're seeing a real shift from illicit to pharmaceutical opioids implicated in these deaths, affecting a broader range of people who want to manage their pain.”</p> <p>Opioids are powerful painkillers that, while once used primarily by cancer patients, are now much more mainstream. Extremely addictive, those hooked on the drugs could start consuming up to 90 tablets a day.</p> <p>“There's good research showing there's been a four-fold increase in the prescribing of these drugs between 1990 and 2014, particularly for Oxycontin, Tramadol and Fentanyl,” explained Roxburgh. “I think doctors need to prescribe for a shorter time and have the patient come in again for a review before they prescribe more.”</p> <p>As a result of the research, Roxburgh is urging the government to introduce tougher legislation, a national clinical guideline or a real-time monitoring program. “We also need to invest in pain programs that don't involve long-term medication, such as ones that are behaviourally and psychologically based.”</p>

News

Our Partners